CADM1, which was previously discovered as a tumor suppressor in lung cancer [21], has been revealed to be highly and exclusively expressed in HTLV-1-infected cells in the peripheral blood (PB) regardless of the ATL subtype [22,23]. Here, CADM1 is linked to lung cancer.